[go: up one dir, main page]

ES2169942T3 - Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil. - Google Patents

Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil.

Info

Publication number
ES2169942T3
ES2169942T3 ES99902686T ES99902686T ES2169942T3 ES 2169942 T3 ES2169942 T3 ES 2169942T3 ES 99902686 T ES99902686 T ES 99902686T ES 99902686 T ES99902686 T ES 99902686T ES 2169942 T3 ES2169942 T3 ES 2169942T3
Authority
ES
Spain
Prior art keywords
treatment
lanolin
trinitrate
glycerile
erectile dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99902686T
Other languages
English (en)
Inventor
Colin Anthony Kemp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUTURA MEDICAL DEV Ltd
Original Assignee
FUTURA MEDICAL DEV Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUTURA MEDICAL DEV Ltd filed Critical FUTURA MEDICAL DEV Ltd
Application granted granted Critical
Publication of ES2169942T3 publication Critical patent/ES2169942T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Prostheses (AREA)
  • Drying Of Semiconductors (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)

Abstract

Uso de una combinación de compuestos en la preparación de una composición para aplicación tópica al pene para el tratamiento de la disfunción eréctil en los varones, caracterizado porque los compuestos comprenden trinitrato de glicerilo como único ingrediente activo y lanolina.
ES99902686T 1998-01-30 1999-01-28 Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil. Expired - Lifetime ES2169942T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802078.7A GB9802078D0 (en) 1998-01-30 1998-01-30 Preparation for treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
ES2169942T3 true ES2169942T3 (es) 2002-07-16

Family

ID=10826219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99902686T Expired - Lifetime ES2169942T3 (es) 1998-01-30 1999-01-28 Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil.

Country Status (17)

Country Link
EP (2) EP0934744A1 (es)
JP (1) JP2002501893A (es)
KR (1) KR100595413B1 (es)
CN (1) CN1292691A (es)
AT (1) ATE211650T1 (es)
AU (1) AU747085B2 (es)
BR (1) BR9908358A (es)
CA (1) CA2319202A1 (es)
DE (1) DE69900774T2 (es)
DK (1) DK1049461T3 (es)
ES (1) ES2169942T3 (es)
GB (1) GB9802078D0 (es)
ID (1) ID26132A (es)
IL (2) IL137561A0 (es)
NZ (1) NZ506580A (es)
PT (1) PT1049461E (es)
WO (1) WO1999038506A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE318563T1 (de) * 2001-03-30 2006-03-15 Futura Medical Dev Ltd Kondom mit einer erektogenen zusammensetzung
GB0417675D0 (en) 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB0602224D0 (en) 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
GB201121204D0 (en) 2011-12-09 2012-01-18 Lrc Products A pack containing a condom
CN104161617A (zh) * 2014-08-29 2014-11-26 蔺莹莹 一种新型避孕套及其制备方法
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
AU2019254237B2 (en) 2018-04-16 2025-01-30 Onquality Pharmaceuticals China Ltd. Method for preventing or treating side effects of cancer therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572108A (en) * 1978-11-27 1980-05-30 Sanwa Kagaku Kenkyusho:Kk Preparation for transcutaneous administration, composed mainly of nitroglycerine
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
IE54286B1 (en) * 1983-01-18 1989-08-16 Elan Corp Plc Drug delivery device
CA1328813C (en) * 1986-11-06 1994-04-26 Hiroshi Tanaka Skin irritation alleviation agent and composition thereof
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
JPH02200633A (ja) * 1989-01-27 1990-08-08 Akamatsu Shoji Kk 血管拡張剤
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
RU2036644C1 (ru) * 1994-01-05 1995-06-09 Олег Борисович Лоран Средство для нормализации половой потенции мужчин

Also Published As

Publication number Publication date
JP2002501893A (ja) 2002-01-22
NZ506580A (en) 2003-05-30
WO1999038506A3 (en) 1999-09-30
KR100595413B1 (ko) 2006-07-03
DE69900774T2 (de) 2002-08-14
ATE211650T1 (de) 2002-01-15
PT1049461E (pt) 2002-07-31
EP1049461B1 (en) 2002-01-09
GB9802078D0 (en) 1998-03-25
DK1049461T3 (da) 2002-04-15
AU747085B2 (en) 2002-05-09
EP1049461A2 (en) 2000-11-08
WO1999038506A2 (en) 1999-08-05
CN1292691A (zh) 2001-04-25
EP0934744A1 (en) 1999-08-11
DE69900774D1 (de) 2002-02-28
CA2319202A1 (en) 1999-08-05
HK1033647A1 (en) 2001-09-14
AU2289899A (en) 1999-08-16
KR20010040488A (ko) 2001-05-15
ID26132A (id) 2000-11-23
BR9908358A (pt) 2002-12-31
IL137561A (en) 2006-12-31
IL137561A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
BR0314354A (pt) Formação para gentes lipofìlicos
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
BR9500555A (pt) Composição cosméticas de uso tópico,processo de preparação de composições,utilização de composições e processo de tratamento cosmético
BR9702147A (pt) Composição farmacéutica uso de uma composição farmacéutica e processo para o tratamento da dor associada com escarificação periodontal e para a preparação de uma composição farmacéutica
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
ATE156700T1 (de) Mundwasserkonzentrat zur wirksamen abgabe antimikrobieller mittel
TR199802423T2 (xx) Konsantre antikor terkibi.
ATE239498T1 (de) Entzündungshemmende zusammensetzung
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
PT1089704E (pt) Locao tricologica para aplicacao topica
AR019261A1 (es) Cetoazalido de la clase de lactamas de 15 miembros, su uso, procedimiento para prepararlo , y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animales
ITMI981586A0 (it) Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
AR004052A1 (es) Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico
BR9711225A (pt) Composi-{es de propentofilina transd-rmica para o tratamento do mal de alzheimer
ES2169942T3 (es) Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil.
ES2061828T3 (es) Composiciones antiirritantes y desensibilizadoras y metodos para su uso.
ITPN920030A0 (it) Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1049461

Country of ref document: ES